Check out our most popular compounded medications! Get Started
Description: This compounded formulation combines Dehydroepiandrosterone (DHEA) at a dose of 5 mg with Progesterone at a dose of 100 mg in a slow-release oral capsule. Utilizing Methocel E4M, a hydrophilic matrix forming polymer, the capsules are engineered to deliver the active ingredients over an extended period. This controlled-release mechanism ensures a steady absorption rate, which can lead to more consistent blood levels of the hormones, potentially reducing the need for frequent dosing and enhancing patient adherence to the treatment regimen.
The Dehydroepiandrosterone (DHEA) component is a steroid hormone precursor, which can be converted into active sex hormones in the body and is used for a variety of indications, including adrenal insufficiency, depression, induction of labor, and systemic lupus erythematosus. Progesterone is a natural hormone important for regulating ovulation and menstruation. In combination, this formulation may be prescribed for hormone replacement therapy, particularly in postmenopausal women, or for the treatment of specific gynecological conditions that benefit from hormone supplementation.
By providing a slow and sustained release of hormones, this formulation aims to mimic the body's natural rhythm, potentially reducing side effects associated with hormone peaks and troughs. It is important to note that the use of this compounded formulation should be guided by a healthcare professional, with consideration given to the individual patient's hormonal needs and health profile.
Licensed to fill prescriptions for patients in RI, MA, CT, NJ, NH, FL, ME and PA. New York patients are served on a limited basis while nonresident registration is pending.
Our Dehydroepiandrosterone (DHEA) 5 mg/Progesterone 100 mg Slow Release Oral Capsules are meticulously formulated to provide a controlled release of hormones over an extended period. The incorporation of Methocel E4M, a hydrophilic methylcellulose polymer, allows for a gradual and consistent release of the active ingredients, ensuring a steady hormonal level in the bloodstream. This slow-release mechanism is particularly beneficial for maintaining hormonal balance without the peaks and troughs associated with immediate-release formulations.
DHEA is a naturally occurring hormone that serves as a precursor to sex hormones such as estrogen and testosterone. Supplementation with DHEA may help to improve age-related decline in hormone levels, support adrenal function, and enhance overall well-being. Progesterone, another vital hormone, is essential for regulating the menstrual cycle and maintaining pregnancy. It also has a role in bone health, cardiovascular function, and neuroprotection. The combination of DHEA and Progesterone in our formulation is often used to address conditions such as adrenal insufficiency, estrogen dominance, premenstrual syndrome (PMS), menopausal symptoms, and as part of hormone replacement therapy (HRT).
By using a slow-release capsule, patients may experience fewer side effects and a more convenient dosing schedule, which can lead to better adherence to the prescribed therapy. This is particularly important for hormones like progesterone, which can cause drowsiness or other side effects if released too quickly into the bloodstream. The slow-release formulation allows for once or twice-daily dosing, which can be more manageable for patients compared to multiple doses throughout the day.
It is important for prescribers to consider individual patient needs when recommending this formulation, as hormone therapy can be highly personalized. Monitoring hormone levels and adjusting dosages may be necessary to achieve optimal therapeutic outcomes. Patients should be advised of the potential benefits and risks associated with hormone supplementation and should be monitored regularly for any adverse effects or changes in their condition.
For more detailed information or if you have any questions regarding our Dehydroepiandrosterone 5 mg/Progesterone 100 mg Slow Release Oral Capsules, please do not hesitate to reach out to us at Bayview Pharmacy. Our team of expert compounding pharmacists is dedicated to providing high-quality, individualized care to meet the unique needs of each patient.
Dehydroepiandrosterone (DHEA) and progesterone are hormones that play significant roles in the human body, with DHEA being a precursor to sex hormones and progesterone being a key component in the menstrual cycle and pregnancy. When combined in a slow-release oral capsule formulation, these hormones can be used to treat a variety of conditions, including certain hormonal deficiencies, menopausal symptoms, and as part of hormone replacement therapy. However, it is crucial to consider potential drug interactions when prescribing or taking this medication.
Firstly, DHEA may interact with medications that are metabolized by the liver. Since DHEA is metabolized by cytochrome P450 enzymes, particularly CYP3A4, it may affect the metabolism of other drugs that are substrates of this enzyme, potentially leading to altered drug levels and effects. Patients taking medications such as certain anticonvulsants, immunosuppressants, or protease inhibitors should be monitored closely for any changes in drug efficacy or side effects.
Progesterone, on the other hand, may interact with drugs that induce or inhibit hepatic enzymes, particularly CYP3A4. Drugs that induce CYP3A4, such as rifampin or certain anticonvulsants, may decrease the levels and effectiveness of progesterone. Conversely, CYP3A4 inhibitors like ketoconazole or erythromycin may increase progesterone levels, potentially leading to an increased risk of side effects. Additionally, progesterone may alter the effectiveness of anticoagulants, such as warfarin, necessitating closer monitoring of coagulation parameters and possible dose adjustments.
Both DHEA and progesterone may also interact with other hormonal therapies, including estrogen and testosterone, which could lead to an imbalance in hormone levels and increased risk of side effects. It is important to assess the patient's current hormone therapy regimen before initiating treatment with DHEA and progesterone slow-release capsules.
Furthermore, the use of DHEA and progesterone may influence insulin sensitivity and glucose metabolism. Patients with diabetes or those taking antidiabetic medications should be monitored for changes in blood glucose levels and may require adjustments to their diabetic medication regimen.
It is also important to note that the slow-release formulation of this medication, utilizing Methocel E4M, may interact with other medications by altering the gastric residence time and potentially affecting the absorption of concurrently administered oral drugs. Patients should be advised to follow the prescribed dosing schedule and to discuss any new medications with their healthcare provider to ensure proper management of potential interactions.
Patients and prescribers should be aware of these potential interactions and monitor for any adverse effects or changes in therapeutic outcomes. Regular follow-up and communication with the healthcare team are essential for safe and appropriate use of this medication. If you have any questions or concerns regarding this formulation or its interactions with other drugs, please reach out to us at Bayview Pharmacy for further assistance.
The Dehydroepiandrosterone (DHEA) 5 mg/Progesterone 100 mg Slow Release (MEM4) Oral Capsules are a specialized formulation designed to provide a steady release of hormones into the bloodstream. This is achieved through the use of Methocel E4M, a hydrophilic polymer that forms a gel matrix when it comes into contact with gastric fluids. Methocel E4M is a type of hypromellose, which is widely used in pharmaceutical formulations as a controlled-release agent due to its ability to swell and form a viscous gel barrier. This gel barrier controls the rate at which the active ingredients, DHEA and Progesterone, are released from the capsule and absorbed by the body.
DHEA is a naturally occurring hormone that serves as a precursor to sex hormones such as estrogen and testosterone. It is involved in a wide range of biological functions, including immune response, energy level, mood, and libido. Progesterone is another natural hormone that plays a key role in the menstrual cycle and in maintaining the early stages of pregnancy. It also has a variety of other health benefits, such as promoting bone density and cardiovascular health. The combination of DHEA and Progesterone in a slow-release formulation can help in restoring hormonal balance and addressing conditions such as adrenal insufficiency, where the body does not produce adequate amounts of certain hormones, and menopausal symptoms, including hot flashes, mood swings, and vaginal dryness.
The slow-release mechanism of the MEM4 capsule ensures that the hormones are not released all at once, but rather gradually over an extended period. This mimics the body's natural rhythm of hormone release more closely than immediate-release formulations. As a result, patients may experience a more consistent therapeutic effect with fewer fluctuations in hormone levels, which can reduce the occurrence of side effects. Additionally, the sustained release of hormones allows for less frequent dosing, which can improve patient compliance and convenience.
For prescribers, it is important to note that the slow-release formulation of DHEA and Progesterone may require monitoring to ensure that hormone levels are maintained within the therapeutic range. Adjustments to the dosage may be necessary based on individual patient response and laboratory results. The use of this formulation should be part of a comprehensive treatment plan that includes regular follow-up and assessment of treatment efficacy and safety.
Patients interested in this formulation should consult with their healthcare provider to determine if it is appropriate for their specific condition. Prescribers and patients can reach out to Bayview Pharmacy with any questions regarding the formulation, its mechanism of action, or its suitability for treating specific disease states. Our team of compounding pharmacists is equipped to provide detailed information and support to ensure optimal treatment outcomes.
This compounded formulation is designed to provide a combination of hormones, Dehydroepiandrosterone (DHEA) and Progesterone, in a controlled-release manner. It is intended for people who may need supplementation with these hormones and can benefit from a steady release of the medication over an extended period of time.
These capsules are formulated with Methocel E4M, a type of controlled-release polymer, which allows the medication to be released gradually over time. This creates a sustained therapeutic effect and aims to improve patient compliance by reducing the frequency of dosing.
Methocel E4M is a type of hydrophilic polymer used in pharmaceutical formulations to control the release rate of the active ingredients. When the capsule is ingested, Methocel E4M forms a gel-like matrix in the presence of gastric fluids, which slows down the release of the medication, ensuring a prolonged therapeutic effect.
No, as this is a slow-release formulation, the effects will not be immediate. The active ingredients are released gradually to provide a consistent level of medication over an extended period.
The dosing frequency will depend on the advice of your healthcare provider, but typically, due to the controlled-release nature of these capsules, the dosing frequency may be less than that of immediate-release formulations.
The slow-release mechanism does not affect the potency, but it does change the release profile of the medication. This means you receive a steady amount of medication over time instead of a quick release that might cause fluctuations in blood levels.
Not everyone may be suitable for this type of hormone therapy. It is essential to consult with a healthcare provider to determine if this compounded formulation is appropriate based on your individual health needs and conditions.
It's best to follow the advice of your healthcare provider regarding food intake when taking these capsules. Food can affect the absorption of medication, and your healthcare provider can give you the most appropriate instructions based on this specific formulation.
If you miss a dose, contact your healthcare provider for instructions. Do not double the dose to make up for the missed one, as this could lead to an overdose or unwanted side effects due to the compounded nature of the medication.
Store the capsules at room temperature, away from direct light, moisture, and heat. Keep the bottle tightly closed when not in use to preserve the integrity of the medication. Always keep medications out of reach of children and pets.
Like all medications, this compounded formulation may cause side effects. Some common side effects can include headaches, mood swings, and gastrointestinal discomfort. It's important to discuss the potential side effects and their likelihood with your healthcare provider.
This formulation is compounded by Bayview Pharmacy on a prescriber's order for an individual patient. It is not an FDA-approved drug product, and the FDA has not evaluated it for safety, effectiveness, or manufacturing quality.
A valid prescription is required. Availability depends on Bayview's licensure in your state. This page is general information, not medical advice. Discuss your situation with a licensed healthcare provider.
Search by NCPDP 4106882, or by name and ZIP: Bayview Pharmacy, Warwick, RI 02886. Select it as the destination pharmacy and save it as a favorite. Click any value to copy it.
Compounded preparations have no NDC, so this formula will not appear in your EHR's drug search. Use your system's compound, non-formulary, or free-text prescription entry and name the preparation exactly as written in step 3. If your EHR forces you to pick a listed drug, pick the closest entry for the active ingredient and put the full formula in the prescription body (the Sig or directions field), not in Notes to Pharmacy.
Compounded preparations have no NDC and will not appear in your drug search. For EPCS to validate, select a drug entry your EHR recognizes as controlled, usually the bulk powder entry for the active ingredient (for example Ketamine (bulk) powder, not a branded product), then put the full formula from step 3 in the prescription body. A free-text entry that does not validate as controlled will be rejected by your EPCS module.
Quantity and directions are starting points for this dose form, not treatment recommendations. Dosing remains the prescriber's responsibility.
Transmit from your EHR. For this non-controlled preparation we also accept fax to (401) 284-4506 and phoned orders at (401) 284-4505. Order forms are on the formulation pages and in the prescriber portal.
Transmit with two-factor authentication through your EPCS-enabled EHR. No order form is offered for this preparation; e-prescribing guides for our controlled preparations are on the formulation pages.
Licensed to dispense in RI, MA, CT, NJ, NH, FL, ME, and PA; New York is served on a limited basis while nonresident registration is pending. Compounded preparations are not FDA-approved. A valid prescription is required. Full guide, including steps by EHR: How to e-prescribe to Bayview. Questions about this formula: call (401) 284-4505.
Take 1 capsule by mouth
